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Expanding the evidence within evidence-based healthcare:
thinking about the context, acceptability and feasibility
of interventions
Rachel L Shaw,1 Michael Larkin,2 Paul Flowers3
Abstract
Evidence-based medicine is crucial to contemporary
healthcare. It is dependent on systematic review method-
ology modelled on an arguably inadequate hierarchy of
evidence. There has been a signiﬁcant increase in
medical and health research using qualitative and mixed
method designs. The perspective taken in this article is
that we need to broaden our evidence base if we are to
fully take account of issues of context, acceptability and
feasibility in the development and implementation of
healthcare interventions. One way of doing this is to use
a range of methods that better ﬁt the different aspects of
intervention development and implementation. Methods
for the systematic review of evidence, other than rando-
mised-controlled trials, are available and there is a
readiness to incorporate these other types of evidence
into good-practice guidance, but we need a clear meth-
odology to translate these advances in research into the
world of policy.
Delivering evidence-based healthcare is a
complex interpersonal process
Evidence-based healthcare (EBHC) depends on collating
research evidence, communicating ﬁndings and translat-
ing ﬁndings into best-practice guidance that can be
implemented in real-world practice. Cochrane’s deﬁn-
ition of EBHC highlights the centrality of the clinician–
evidence relationship to bridge the gap between research
and practice (see: http://www.cochrane.org/about-us/
evidence-based-health-care#REF1). How clinicians feel
about evidence can have an impact on the degree of
ﬁdelity with which healthcare interventions are imple-
mented.1 As such there are critical differences between
evidence of efﬁcacy and effectiveness. All evidence-
based interventions, whether biomedical, social or struc-
tural, involve interpersonal processes and are “delivered
in the context of an encounter between a health profes-
sional and a patient, making healthcare professional
clinical behaviours an important proximal determinant
of the quality of care that patients receive.”2
Thus, interpersonal relationships and communication
are fundamental to implementation science. This jars with
most understandings of the role of evidence within guide-
line formation, which disproportionately privileges
large-scale population-based studies. Such studies are
vital tests of efﬁcacy and cost-effectiveness, yet poor at
understanding implementation. The current evidence hier-
archy used to help shape guidance production (eg, by
National Institute for Health and Care Excellence (NICE)
and the Scottish Intercollegiate Guideline Network (SIGN))
struggles to incorporate qualitative and mixed methods
research, and thus lacks systematic analyses of the context
and experience of implementing interventions. Clinicians
and commissionersi need to understand the interactions,
relationships and sociocultural contexts that shape the
acceptability and meaningfulness of healthcare interven-
tions. To complete the cycle of translating ﬁndings into
‘practice-ready’ guidance it is necessary to consider the
human systems within which an intervention is to be
implemented. This is an iterative process, as described in
the Medical Research Council’s (MRC) framework for
developing complex behavioural interventions (see: http://
www.mrc.ac.uk/Utilities/Documentrecord/index.htm?
d=MRC004871).
A complete evidence base must inform healthcare
guidance. This should develop from a pluralistic model
of research; address translational and implementation
questions; draw upon different methods for different
questions; provide diverse evidence on which to base
best-practice guidance.
What is missing from conventional accounts
of how ‘best evidence’ informs practice?
We know that within the hierarchy of evidence, system-
atic reviews of randomised controlled trials (RCTs) sit at
the top as the ‘gold standard’ and are key to informing
guidance.3 This is unsurprising because they report on
efﬁcacy and/or cost-effectiveness of interventions in
terms which provide clear messages for policy-makers.
However, as Sackett’s discussion of evidence-based
medicine made clear, when faced with an individual
patient, an RCT may not provide coherent advice.4
Instead, Sackett emphasised the need for both clinical
expertise and current best evidence because without
both, practice will suffer to the detriment of patients.
Balancing insights from cumulative knowledge and
taking a negotiated and tailored approach to each
patient represents the best approach.
While the traditional hierarchy of evidence is vital in
understanding cumulative knowledge and healthcare
delivery, it is not without its shortcomings. The vital
focus on objective, measurable and controllable ways of
looking at healthcare at a population level mean that
social context and individual experience are discounted;
the patient and the clinician are both reduced to
cyphers. To be useful, best-practice guidance must be
adaptable to real-world practice scenarios, that is, take
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account of the cultural and psychosocial context. This is
the task of translational research which emphasises
working within real-world environments, partnerships,
stakeholder consultations and often involves qualitative
and/or mixed methods designs.5 6
Incorporating experience and context into
healthcare evidence
There has been a substantial rise in the use qualitative
and mixed methods research in medical and healthcare
settings in the past 20 years which has provided great
insight into the value and accessibility of healthcare ser-
vices.7 8 Furthermore, it has shown us how patients
make sense of their own health, whether the health
information provided is clear and appropriate and
whether healthcare professionals feel competent when
explaining complex risks associated with diagnosis or
treatment regimens.9 10
Some ground has been gained in recent moves by
funding bodies, particularly the UK government funding
programme—National Institute for Health Research (NIHR)—
to foreground patient perspectives in designing and con-
ducting research through patient, carer and public involve-
ment (PCPI; eg,:http://www.crncc.nihr.ac.uk/about_us/
stroke_research_network/in_your_area/south_west/Patients_
carers). A review of patient involvement has demonstrated
that it can be cost-effective and has been adopted in a range
of research designs including RCTs, naturalistic studies, par-
ticipatory and political action research.11 12 As such, PCPI
has sanctioned the utility of patient and carer perspectives.
Nevertheless, it remains an initiative to involve patients in
the research process, rather than expanding the types of
methods used in designing services. Patient perspectives
remain absent from the process by which evidence becomes
guidance. Although patients increasingly help set research
agendas, unless their perspectives are turned into high-
quality peer-reviewed papers, they will not shape guidance
production.
The added value of qualitative and mixed
methods research
To incorporate experience and context into the evidence
base, alongside efﬁcacy and cost-effectiveness, to
provide useful best-practice guidance that can deal with
multiple formulations at the population, systemic and
individual levels, we require a wider range of research
questions and methods and a more balanced view of
their value. Mixed methods designs and qualitative
research offer systematic ways of exploring the sociocul-
tural context within which healthcare services must be
designed and delivered; they provide means of gathering
and analysing patients’ perspectives, features of interac-
tions between patients and practitioners, language used
in health information and tools to understand patient
expectations and satisfaction; and they can help us
understand key relationships at the level of family, com-
munity, health and social care organisations and gov-
ernment. NICE’s conceptual framework puts the patients’
lifeworld at the centre.13 This refers to all of the socio-
economic, cultural and historical aspects of our lives; it
includes our relationships, geography and our ability to
take control, or have agency, in our interactions with
healthcare providers and policy-makers. The centrality
of the lifeworld requires that we be open to a broad
range of research questions and designs and that we use
the best-ﬁt methods for the questions we ask. This may
involve multiple qualitative methods, qualitative and
quantitative methods or more than one quantitative
method.14 The outcomes of such research can help us to
understand not only the role of experience and context
in the implementation of interventions but can also help
us to develop future interventions, and future evalua-
tions of the effectiveness of those interventions. They
are, therefore, likely to be important to the users of
research.15 Critically then, the centrality of the lifeworld
means that we must be open to including the outcomes
of such research in syntheses of evidence, and in the
development of guidance to inform best practice.
Systematic reviews of diverse evidence
The value of qualitative research is clear but there
remains a gap between high-quality primary qualitative
research and its systematic review for inclusion in good-
practice guidance.16 That is not to say that methods for
systematically reviewing qualitative evidence do not
exist.17 Furthermore, UK bodies NICE and SIGN have
declared their commitment to qualitative evidence as
essential, alongside more ‘traditional’ (ie, quantitative)
sources of evidence, in understanding healthcare and
subsequently in producing guidelines for best clinical
practice. For this work to be translated into the policy
and practice world, we need a clear methodology. The
Cochrane Collaboration Qualitative Methods and
Implementation Group in the UK (see: http://cqim.
cochrane.org/) and the Patient-Centered Outcomes
Research Institute in the USA (see: http://www.pcori.org/)
have begun this work. Signiﬁcant advancements in
appraisal tools for diverse evidence have been accom-
plished18 but focused efforts are still required to establish
rigorous methods for synthesis of quantitative and quali-
tative data. Integrative and aggregative synthesis
methods have been proposed.17 The EPPI (Evidence for
Policy and Practice Information and Co-ordinating
Centre at the Institute of Education, London) approach
involves the parallel synthesis of, for example, interven-
tion studies (quantitative methods) and perspectives
studies (qualitative methods). This is not an integrative
approach because ﬁndings from studies with different
designs are dealt with separately before being brought
together in a ‘mosaic’ to answer the research question.19
A recent proposal for ‘best-ﬁt’ framework synthesis gen-
erates an a priori framework from literature describing
conceptual models or theories. Next, deductive (using the
framework) and inductive coding (data-driven) using
principles of thematic analysis are used to perform the
synthesis.20 While currently proposed for the synthesis of
qualitative evidence alone, there is potential to adapt this
integrative method of synthesis for use with diverse
evidence.
Once a rigorous methodology for systematic review
and synthesis of diverse evidence is recognised, the next
challenge is determining how such evidence will mani-
fest in best-practice guidance. As indicated above, quali-
tative and mixed methods evidence will advise
practitioners in their everyday encounters with patients
in individual or group settings. Additionally, it will
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inform the development of strategies for designing inter-
ventions that are feasible in different contexts and that
generate patient acceptance across a range of socio-
economic and geographical groupings. In short, incorp-
orating diverse evidence into EBHC will produce
guidance encompassing best practice at the population,
systemic and individual levels.
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